Drug class
Angiotensin II Receptor Antagonists (ARBs)
Angiotensin II receptor antagonists, commonly known as angiotensin receptor blockers (ARBs), are a class of cardiovascular medications that selectively block the binding of angiotensin II to angiotensin II type 1 (AT1) receptors. Read more about Angiotensin II Receptor Antagonists (ARBs)
281 drugs in this class 82 manufacturers
Drugs in Angiotensin II Receptor Antagonists (ARBs)
VALSARTAN
VALSARTAN
VALSARTAN
AMLODIPINE-VALSARTAN (amlodipine besylate/valsartan)
AMLODIPINE-VALSARTAN (amlodipine besylate/valsartan)
LOSARTAN POTASSIUM
AMLODIPINE-VALSARTAN-HCTZ (amlodipine besylate/valsartan/hydrochlorothiazide)
ENTRESTO (sacubitril/valsartan)
Angiotensin II receptor antagonists, commonly known as angiotensin receptor blockers (ARBs), are a class of cardiovascular medications that selectively block the binding of angiotensin II to angiotensin II type 1 (AT1) receptors.
By preventing the downstream vasoconstrictive and aldosterone-secreting actions of the renin-angiotensin-aldosterone system, these agents promote vasodilation, enhance sodium and water excretion, and reduce vascular resistance.
Clinically, ARBs are widely prescribed as primary therapies for managing hypertension, treating heart failure, and slowing the progression of chronic kidney disease, particularly diabetic nephropathy.
-
nih.gov
Angiotensin II receptor antagonists, commonly known as angiotensin receptor blockers (ARBs), are a class of cardiovascular medications that selectively block the binding of angiotensin II to angiotensin II type 1 (AT1) receptors By preventing the downstream vasoconstrictive and aldosterone-secreting actions of the renin-angiotensin-aldosterone system, these agents promote vasodilation, enhance sodium and water excretion, and reduce vascular resistance Clinically, ARBs are widely prescribed as pr...
-
fda.gov
By preventing the downstream vasoconstrictive and aldosterone-secreting actions of the renin-angiotensin-aldosterone system, these agents promote vasodilation, enhance sodium and water excretion, and reduce vascular resistance Clinically, ARBs are widely prescribed as primary therapies for managing hypertension, treating heart failure, and slowing the progression of chronic kidney disease, particularly diabetic nephropathy
-
nih.gov
By preventing the downstream vasoconstrictive and aldosterone-secreting actions of the renin-angiotensin-aldosterone system, these agents promote vasodilation, enhance sodium and water excretion, and reduce vascular resistance
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.